Spongilla (Herbal raw material, Powder) Instructions for Use

ATC Code

D11AX (Other drugs used in dermatology)

Active Substance

Spongilla lacustris (Grouping name)

Clinical-Pharmacological Group

Drug of animal origin with local irritant, anti-inflammatory and analgesic action

Pharmacotherapeutic Group

Local irritant of natural origin

Pharmacological Action

A local irritant agent obtained from the freshwater sponge Spongilla, which represents colonies of coelenterate animals – Spongilla lacustris fragilis, Ephydatia fliviatilis.

The sponge lives only in exceptionally clean freshwater bodies with flowing water and at specific temperatures.

The skeleton of Spongilla consists of a looped network of silica needles bound together by an organic substance – spongin. It also includes phosphates, carbonates, and organic substances.

The action of Spongilla is based on mechanical irritation of the skin due to the content of silicon needles.

Indications

Apply externally for the symptomatic relief of pain and inflammation associated with musculoskeletal conditions and minor injuries.

• Radiculitis
• Arthritis
• Rheumatism
• Bruises

The therapeutic effect is achieved through counter-irritation, which modulates pain perception.

ICD codes

Dosage Regimen

Apply the powder externally to the affected areas of the skin. Use as directed for the specific condition being treated.

The frequency of application is typically determined by the severity of symptoms and patient response. Discontinue use if excessive skin irritation, redness, or pain occurs.

Herbal raw material, Powder

Apply externally to the affected areas of the skin.

Adverse Reactions

The most common adverse reactions are localized and related to the product’s mechanism of action.

Possible reactions include transient skin hyperemia, erythema, and pruritus. Allergic reactions, including contact dermatitis, are possible, especially in individuals with known sensitivity.

Contraindications

Do not use under the following conditions.

• Hypersensitivity to Spongilla or any component of the product.
• Impaired skin integrity, including open wounds, cuts, abrasions, or severe dermatitis, at the sites of intended application.
• Application to areas with active infection or acute inflammatory skin conditions.

Avoid contact with mucous membranes, such as the eyes and nose.

Drug Interactions

No specific drug interactions are known. Exercise caution when applying to the same area as other topical medications, as the mechanical irritation may alter skin permeability.

Concurrent use with other topical irritants or exfoliants may increase the risk of severe skin reactions.

Overdose

Overdose manifests as severe local skin reactions, including intense erythema, blistering, pain, and swelling.

In case of overdose, immediately discontinue use and thoroughly wash the affected area with water. Treatment is symptomatic and supportive. Seek medical attention if a severe reaction occurs.

Special Precautions

Do not apply Spongilla to the mucous membrane of the nose and eyes; wash off Spongilla with water in case of contact.

To exclude the occurrence of an allergic reaction, it is recommended to apply a minimal amount of the Spongilla solution to the inner surface of the arm.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.